価格表

在庫・価格 : 2024年05月05日 05時38分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Phospho-Immunoreceptor Array Kit, Human, Proteome Profiler
データシート※最新のデータシートでない場合があります
ARY004B RSDアールアンドディー システムス
R&D Systems, Inc.
1 kit ¥143,000
(未発注)
追加

在庫・価格 : 2024年05月05日 05時38分 現在

Phospho-Immunoreceptor Array Kit, Human, Proteome Profiler

  • 商品コード:ARY004B
  • メーカー:RSD
  • 包装:1kit
  • 価格: ¥143,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Atanackovic D et al. Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma. Haematologica 2011 Oct;96(10):1512-20
Atanackovic D et al
2011/01/01
PubMed
2 Kotani N et al. Fibroblast growth factor receptor 3 (FGFR3) associated with the CD20 antigen regulates the rituximab-induced proliferation inhibition in B-cell lymphoma cells. J. Biol. Chem. 2012 Oct;287(44):37109-18
Kotani N et al
2012/01/01
PubMed
3 Son M et al. Evidence for C1q-mediated crosslinking of CD33/LAIR-1 inhibitory immunoreceptors and biological control of CD33/LAIR-1 expression. Sci Rep 2017 Mar;7(1):270
Son M et al
2017/01/01
Sample Type: Cell Lysates PubMed
4 Achieng AO et al. Molecular basis of reduced LAIR1 expression in childhood severe malarial anaemia: Implications for leukocyte inhibitory signalling. EBioMedicine 2019 Jul;45:278-289
Achieng AO et al
2019/01/01
PubMed
5 Herbster S et al. Low RECK Expression Is Part of the Cervical Carcinogenesis Mechanisms. Cancers (Basel) 2021 May;13(9)
Herbster S et al
2021/01/01
Species: Human PubMed
  • No.: 1
  • 文献情報:
    Atanackovic D et al. Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma. Haematologica 2011 Oct;96(10):1512-20
    Atanackovic D et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Kotani N et al. Fibroblast growth factor receptor 3 (FGFR3) associated with the CD20 antigen regulates the rituximab-induced proliferation inhibition in B-cell lymphoma cells. J. Biol. Chem. 2012 Oct;287(44):37109-18
    Kotani N et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Son M et al. Evidence for C1q-mediated crosslinking of CD33/LAIR-1 inhibitory immunoreceptors and biological control of CD33/LAIR-1 expression. Sci Rep 2017 Mar;7(1):270
    Son M et al
    2017/01/01
  • 備考:
    Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Achieng AO et al. Molecular basis of reduced LAIR1 expression in childhood severe malarial anaemia: Implications for leukocyte inhibitory signalling. EBioMedicine 2019 Jul;45:278-289
    Achieng AO et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Herbster S et al. Low RECK Expression Is Part of the Cervical Carcinogenesis Mechanisms. Cancers (Basel) 2021 May;13(9)
    Herbster S et al
    2021/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed